Skip to main content
IDWeek 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

150. HIV: Treatment: Friday, 12:15 - 1:30 p.m.

Poster Session: HIV: Treatment

(1590) Resistance to Etravirine, Doravine and Rilpivirine in People Living with HIV Experiencing Virologic Failure to a First-line Antiretroviral Regimen Based on a Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) in a Latin American Country.

Friday, October 13, 2023
12:15 PM – 1:30 PM US ET
Location: Hall B + C

    Presenting Author(s)

  • Verónica Mingrone (she/her/hers)

    M.D., Infectious Diseases Specialist, Master in Clinical Research
    Fundación IDEAA
    CABA, Ciudad Autonoma de Buenos Aires, Argentina

    • Co-Author(s)

  • EL

    Eliana Loiza, n/a

    M.D., Infectious Diseases Specialist.
    Fundación IDEAA
    CABA, Ciudad Autonoma de Buenos Aires, Argentina

  • NP

    Norma Porteiro, n/a

    M.D., Infectious Diseases Specialist.
    Fundación IDEAA
    CABA, Ciudad Autonoma de Buenos Aires, Argentina

  • JB

    Jamile Ballivian, n/a

    M.D., Clinical Investigator
    IECS
    CABA, Ciudad Autonoma de Buenos Aires, Argentina

  • EC

    Ezequiel Córdova, n/a

    M.D., Infectious Diseases Specialist.
    Fundación IDEAA
    CABA, Ciudad Autonoma de Buenos Aires, Argentina